CN1353614A - 治疗慢性心脏病的方法 - Google Patents

治疗慢性心脏病的方法 Download PDF

Info

Publication number
CN1353614A
CN1353614A CN00805115A CN00805115A CN1353614A CN 1353614 A CN1353614 A CN 1353614A CN 00805115 A CN00805115 A CN 00805115A CN 00805115 A CN00805115 A CN 00805115A CN 1353614 A CN1353614 A CN 1353614A
Authority
CN
China
Prior art keywords
bpi
protein product
bpi protein
leu
circulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN00805115A
Other languages
English (en)
Chinese (zh)
Inventor
B·P·吉洛伊尔
P·J·斯坎弄
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TAXAS SYSTEM, University of, Regents of
Xoma Technology Ltd USA
Original Assignee
TAXAS SYSTEM, University of, Regents of
Xoma Technology Ltd USA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TAXAS SYSTEM, University of, Regents of, Xoma Technology Ltd USA filed Critical TAXAS SYSTEM, University of, Regents of
Publication of CN1353614A publication Critical patent/CN1353614A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A61K38/1751—Bactericidal/permeability-increasing protein [BPI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CN00805115A 1999-01-22 2000-01-21 治疗慢性心脏病的方法 Pending CN1353614A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11673699P 1999-01-22 1999-01-22
US60/116,736 1999-01-22

Publications (1)

Publication Number Publication Date
CN1353614A true CN1353614A (zh) 2002-06-12

Family

ID=22368911

Family Applications (1)

Application Number Title Priority Date Filing Date
CN00805115A Pending CN1353614A (zh) 1999-01-22 2000-01-21 治疗慢性心脏病的方法

Country Status (11)

Country Link
US (3) US6509317B1 (https=)
EP (1) EP1143996B1 (https=)
JP (2) JP2002535282A (https=)
CN (1) CN1353614A (https=)
AT (1) ATE239492T1 (https=)
AU (1) AU778001B2 (https=)
CA (1) CA2359681A1 (https=)
DE (1) DE60002552T2 (https=)
MX (1) MXPA01007031A (https=)
NZ (1) NZ513087A (https=)
WO (1) WO2000043028A2 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004517865A (ja) 2000-12-01 2004-06-17 ゾーマ テクノロジー リミテッド Ｂｐｉタンパク質産物またはｂｐｉインヒビターを使用する、周皮細胞増殖の調節
US20110002893A1 (en) * 2008-11-03 2011-01-06 Ut-Battelle, Llc Diagnosis and treatment of congenital heart defects using nell1
US9974759B2 (en) * 2013-05-31 2018-05-22 Indiana University Research And Technology Corporation Beta 2 adrenoceptor antagonists for treating orthostatic hypotension
GB201319621D0 (en) 2013-11-06 2013-12-18 Norwegian University Of Science And Technology Antimicrobial agents and their use in therapy
GB201319620D0 (en) 2013-11-06 2013-12-18 Norwegian University Of Science And Technology Immunosuppressive agents and their use in therapy
WO2018002673A1 (en) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Novel formulations of angiotensin ii receptor antagonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643875A (en) 1994-01-24 1997-07-01 Friedmann; Nadav Human therapeutic uses of bactericidal/permeability increasing (BPI) protein products
US5578568A (en) * 1994-04-22 1996-11-26 Xoma Corporation Method of treating conditions associated with intestinal ischemia/reperfusion
US5646114A (en) * 1994-07-11 1997-07-08 Xoma Corporation Anti-protozoan methods
CN1236320A (zh) * 1996-05-10 1999-11-24 爱克斯欧玛公司 杀菌的/增强通透性的蛋白质产物用于人脑膜炎球菌血症的治疗用途

Also Published As

Publication number Publication date
WO2000043028A9 (en) 2001-09-20
CA2359681A1 (en) 2000-07-27
NZ513087A (en) 2003-02-28
US20030216312A1 (en) 2003-11-20
DE60002552T2 (de) 2004-02-26
US20060171937A1 (en) 2006-08-03
ATE239492T1 (de) 2003-05-15
JP2007126479A (ja) 2007-05-24
EP1143996A4 (de) 2002-04-24
JP2002535282A (ja) 2002-10-22
DE60002552D1 (de) 2003-06-12
AU778001B2 (en) 2004-11-11
AU2734100A (en) 2000-08-07
WO2000043028A2 (en) 2000-07-27
WO2000043028A3 (en) 2000-11-30
US6509317B1 (en) 2003-01-21
EP1143996A2 (en) 2001-10-17
US7045501B2 (en) 2006-05-16
MXPA01007031A (es) 2004-08-12
EP1143996B1 (en) 2003-05-07

Similar Documents

Publication Publication Date Title
AU735058B2 (en) Therapeutic uses of BPI protein products for human meningococcemia
US5912228A (en) Therapeutic compositions comprising bactericidal/permeability-increasing (BPI) protein products
EP0754049B1 (en) Anti-fungal methods and materials
US20030171265A1 (en) Method of treating conditions associated with intestinal ischemia/reperfusion
WO1997044056A1 (en) Therapeutic uses of bpi protein products in humans with hemorrhage due to trauma
JP2007126479A (ja) 慢性心臓疾患を処置する方法
WO1996030037A1 (en) Method of treating conditions associated with burn injuries
CN1312858A (zh) 杀菌/透性增加蛋白缺失类似物
US20040048793A1 (en) Therapeutic peptide-based constructs
WO1998019694A1 (en) Therapeutic uses of bpi protein products in cystic fibrosis patients
US6482796B2 (en) Therapeutic uses of N-terminal BPI protein products in ANCA-positive patients
US6686332B1 (en) Method of treating depressed reticuloendothelial system function
WO2000018798A1 (en) Antifungal and antibacterial peptide
US20030027762A1 (en) Therapeutic uses of BPI protein products in BPI-deficient humans
Scannon Therapeutic uses of BPI protein products for human meningococcemia
HK1019856B (en) Therapeutic uses of bpi protein products for human meningococcemia
HK1014158B (en) Anti-fungal methods and materials

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication